Objective: Splenectomy is performed in 4-32% of cytoreductive surgeries for ovarian cancer. The objective of our study was to assess splenectomy and evaluate its impact on overall and disease-free survival.
Methods: We conducted a retrospective single-center study between January 2000 and December 2016.